Pharmacovigilance / Graduated-Plan Officer
Collection, assessment and reporting of suspected adverse drug reactions and quality defects. Signal management and benefit-risk monitoring per GVP, single point of contact for the competent authority.
AMG § 63a · GVP
Talk to us about Pharmacovigilance / Graduated-Plan Officer
Three lines and you are in our inbox. We reply within one business day.
What is a graduated plan officer?
The graduated plan officer (German: Stufenplanbeauftragter) is the person responsible for pharmacovigilance at a pharmaceutical company in Germany. The officer collects, assesses and reports suspected adverse drug reactions (ADRs) and quality defects, runs signal management and benefit-risk monitoring, and acts as the single point of contact for the competent authority on drug-safety matters. The role is the safety conscience of a marketing authorisation holder.
The legal anchor is § 63a of the Arzneimittelgesetz (AMG). It obliges the holder of a marketing authorisation (pharmaceutical entrepreneur) to appoint a suitably qualified person responsible for pharmacovigilance, who is resident and operates within the European Economic Area, and to notify this person to the competent federal authority. In German law this person is the Stufenplanbeauftragte; the role is closely connected to the Stufenplan, the graduated safety-measures procedure under § 62 AMG by which the authorities and the company react to risks of medicinal products.
The operational standard comes from the Good Pharmacovigilance Practices (GVP), the EU guidelines that detail the pharmacovigilance system, the role of the Qualified Person Responsible for Pharmacovigilance (QPPV) at EU level, signal management, periodic safety reports and risk management. German marketing authorisation holders implement the GVP modules, and the Stufenplanbeauftragte ensures the national obligations are met in parallel with the EU pharmacovigilance system.
The officer must have access to all safety data, the authority to influence the risk management of the products and a direct line to senior management and the competent authority. The marketing authorisation holder remains responsible but relies on the graduated plan officer for the functioning of the pharmacovigilance system.
In practice the role is deadline-driven and evidence-driven. The graduated plan officer ensures that adverse drug reactions are collected, assessed and reported within the required timelines, runs signal management, watches the benefit-risk balance and keeps the pharmacovigilance system master file current. A missed reporting deadline or a gap in the system can trigger regulatory action, so a continuously staffed function with a deputy and clear procedures is essential.
Core duties of the graduated plan officer
- Collect, record and assess suspected adverse drug reactions and quality defects
- Report ADRs and safety information to the competent authority within the required timelines
- Run signal management and detect new or changed risks under the GVP
- Monitor the benefit-risk balance of the company's medicinal products
- Prepare or oversee periodic safety update reports and risk management plans
- Act as single point of contact for the competent authority on pharmacovigilance
- Coordinate graduated plan (Stufenplan) measures under § 62/63a AMG with the authority
- Ensure the pharmacovigilance system master file is current
- Liaise with the EU Qualified Person Responsible for Pharmacovigilance (QPPV)
- Maintain procedures, training and documentation of the pharmacovigilance system
Appointment and qualification
Under § 63a AMG the marketing authorisation holder must appoint a graduated plan officer before placing medicinal products on the market and must notify this person to the competent federal authority (in Germany the BfArM or the Paul-Ehrlich-Institut depending on the product). The officer must be resident and carry out their tasks within the European Economic Area, reflecting the EU-wide nature of the pharmacovigilance system.
The person needs the necessary expertise (Sachkenntnis) in pharmacovigilance. In practice this means a relevant scientific education, typically pharmacy, medicine or a related life science, together with sufficient experience in drug safety and knowledge of the applicable law and the GVP. The officer must be able to assess ADRs, run signal management and judge the benefit-risk balance of medicinal products.
Independence and access are essential. The graduated plan officer must have access to all relevant safety data, the authority to act on the risk management of the products and a reporting line that ensures safety concerns reach senior management and the authority without filtering. The marketing authorisation holder remains legally responsible but must give the officer the position and resources to run the pharmacovigilance system. The appointment and any change of the officer must be notified to the competent authority, and a deputy arrangement is needed to keep the function continuously staffed. The role coordinates closely with the EU QPPV where the company operates across the EEA.
- Holding a marketing authorisation for medicinal products requiring a pharmacovigilance system under § 63a AMG
- Placing medicinal products on the German market
- Obligation to collect and report suspected adverse drug reactions to the authority
- Implementation of the GVP pharmacovigilance system and signal management
- Initiation of graduated plan (Stufenplan) measures under § 62 AMG
- Change of the responsible person requiring renotification to the authority
Where graduated plan officers are needed
- Pharmaceutical manufacturers and marketing authorisation holders
- Generic and biosimilar companies
- Vaccine and biologics producers
- Companies marketing over-the-counter and prescription medicines
- Contract pharmacovigilance and regulatory service providers
- Importers and parallel distributors of medicinal products
- Herbal and traditional medicinal product companies
- Clinical-stage companies transitioning to market authorisation
How CIVAC supports the graduated plan officer role
CIVAC keeps the pharmacovigilance obligations under § 63a AMG and the GVP organised and audit-ready. The appointment of the graduated plan officer and the deputy, the notification to the competent authority and the responsibility scope sit in the documentation pillar, retrievable during an inspection. CIVAC turns recurring duties into tracked tasks: periodic safety report deadlines, signal-management review cycles, training of the pharmacovigilance staff and the maintenance of the system master file are scheduled and routed to the responsible person before they fall due. Reporting timelines for ADRs and graduated plan measures under § 62 AMG are kept visible, so the chain from the AMG and the GVP to the named officer stays traceable and nothing slips on a deadline.
Frequently asked questions
Need this officer role for your organisation?
Appoint our experts as your external officer or license CIVAC for your in-house team. Get in touch and we walk you through the right setup.